Received Jul 4, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | 57H54 | — |
Menveo (1 vial) administration after temperature excursion; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incorrect storage of drug in a 11-year-old female patient who received Men ACWY-CRM NVS (Menveo) (batch number 57H54, expiry date 31-JAN-2026) for prophylaxis. On 18-JUN-2025 08:40, the patient received Menveo. On an unknown date, an unknown time after receiving Menveo, the patient experienced incorrect storage of drug (Verbatim: Menveo (1 vial) administration after temperature excursion). The outcome of the incorrect storage of drug was not applicable. Additional Information: GSK Receipt Date: 24-JUN-2025 The pharmacist called to verify if doses of vaccines that had been exposed to low temperatures (26.5° Fahrenheit). On 18 June 2025 at 08:40 am was administered to the patient which led to incorrect storage of drug. The reporter wanted to know if the dose should be repeated. The Vaccine Administration Facility is the same as Primary Reporter.; Sender's Comments: US-GSK-US2025079375:Same reporter different patient GSK-US2025079381:Same reporter different patient US-GSK-US2025079378:Same reporter different patient US-GSK-US2025079384:Same reporter different patient US-GSK-US2025079387:Same reporter different patient